Clinical Trial Analysisfor "RNA"
Study Phases Distribution
Distribution of trials by study phase
Not Applicable: 87
Phase 1: 76
Phase 2: 52
Phase 3: 21
Phase 4: 13
Early Phase 1: 12
Recruitment Status Distribution
Distribution of trials by recruitment status
Total: 452
Top Countries Distribution
Countries with most clinical trials
Top Companies Distribution
Companies with most clinical trials
| Company | Count |
|---|---|
| BioNTech SE | 19 |
| Medicago | 12 |
| Assiut University | 8 |
| Ain Shams University | 7 |
| University of Florida | 7 |
| University of Pennsylvania | 7 |
| Duke University | 6 |
| Merck Sharp & Dohme LLC | 6 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| Pfizer | 6 |
Top Conditions Distribution
Most studied medical conditions
| Condition | Count |
|---|---|
| RNA Virus Infections | 39 |
| Virus Diseases | 29 |
| Respiratory Tract Infections | 23 |
| COVID-19 | 18 |
| Hepatitis C | 16 |
| Respiratory Tract Diseases | 15 |
| HIV Infections | 13 |
| Breast Cancer | 11 |
| Influenza, Human | 11 |
| Lung Cancer | 10 |
Top Interventions Distribution
Most common intervention types
| Intervention | Count |
|---|---|
| Placebo | 31 |
| RNA analysis | 18 |
| laboratory biomarker analysis | 12 |
| gene expression analysis | 10 |
| RNA sequencing | 9 |
| DNA analysis | 7 |
| immunohistochemistry staining method | 6 |
| microarray analysis | 6 |
| BNT162b2 | 5 |
| polymerase chain reaction | 5 |